Cerebral Small Vessel Disease: a Review of the Pathophysiological Mechanisms

Yousef Hannawi1

  • 1Division of Cerebrovascular Diseases and Neurocritical Care, Department of Neurology, The Ohio State University, 333 West 10th Ave, Graves Hall 3172C, Columbus, OH, 43210, USA. yousefhannawi@yahoo.com.

PubMed

Insights

Cerebral small vessel disease (cSVD) involves aging brain processes affecting small vessels. Understanding these mechanisms is key to developing new treatments for cSVD, which causes cognitive decline and stroke.

Area of Science:

  • Neurology
  • Vascular Biology
  • Aging Research

Background:

  • Cerebral small vessel disease (cSVD) is a major cause of vascular cognitive impairment and stroke.
  • Current understanding of cSVD pathogenesis is incomplete, limiting therapeutic development.

Purpose of the Study:

  • To review and synthesize current knowledge on cSVD pathophysiological mechanisms.
  • To identify knowledge gaps and propose future research directions for cSVD therapeutics.

Main Methods:

  • Review of recent advances in neuroimaging and animal models of cSVD.
  • Analysis of age-dependent processes implicated in cSVD pathogenesis.
  • Discussion of the interaction between various pathological factors.

Main Results:

  • cSVD involves arterial stiffness, oxidative stress, inflammation, gut dysbiosis, and high salt intake.
  • These factors lead to endothelial dysfunction, blood-brain barrier breakdown, and neuroinflammation.
  • Impaired glymphatic system function contributes to cognitive decline in cSVD.

Conclusions:

  • Multiple interacting age-dependent mechanisms drive cSVD.
  • Further research is needed to elucidate complex interactions and develop targeted therapies.
  • A systematic approach to translational and early-phase clinical research is proposed.